Study of KBA1412 in Participants With Advanced Solid Malignant Tumors

Clinical trial NCT05501821 · COMPLETED

Trial details

NCT number: NCT05501821
Sponsor: Kling Biotherapeutics B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Malignancy

Start date: 2022-08-08
Primary completion: 2024-07-24
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.